SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Roka Bioscience, Inc. - ROKA
NEW YORK, Dec. 24, 2014 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Roka Bioscience, Inc. ("Roka" or the "Company") (NasdaqGS: ROKA) (CUSIP: 775431109). Investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 237.
The investigation concerns whether Roka Bioscience, Inc. and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
On July 17, 2014, Roka sold 5.0 million shares of stock in its initial public stock offering (the "IPO"), reaching a high of $13.00 per share the following day. However, just several months after its IPO, on November 6, 2014, the company announced that it lost 64 cents per share in the third quarter ended September 30, 2014.
Additionally, the Company reported that there were no new Atlas® instruments placements, the Company's main product, made during the quarter. On this news, shares of Roka fell $5.34, or more than 64%, on intraday trading to $3.00, on unusually heavy trading volume on November 7, 2014.
The Pomerantz Firm, with offices in New York, Chicago, San Diego, and Florida, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 70 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.
CONTACT:
Robert S. Willoughby
Pomerantz LLP
[email protected]
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-roka-bioscience-inc--roka-300013965.html
SOURCE Pomerantz LLP
Share this article